S6 Insights on”Onc.AI Serial Imaging Response Score Outperforms Traditional Methods for Early Assessment of NSCLC Immunotherapy Outcomes”

In Today’s News: Onc.AI’s new serial imaging response score enhances the early evaluation of NSCLC immunotherapy outcomes, surpassing traditional methods. This AI-driven innovation allows improved identification of long-term survivors at initial follow-up, proving beneficial in oncology clinical management solutions. Origin:…






